Seminars in Nuclear Medicine
Volume 37, Issue 4 , Pages 249-260 , July 2007

Antenatally Detected Hydronephrosis

  • Amy Piepsz, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Amy Piepsz, MD, PhD, Department of Radioisotopes, CHU St. Pierre, 322, Rue Haute, B-1000 Brussels, Belgium.

References 

  1. Ismaili K, Hall M, Donner C, Thomas D, et al. Result of systematic screening for minor degrees of fetal renal pelvis dilatation in an unselected population. Am J Obstet Gynecol. 2003;188:242–246
  2. Pourissa M, Refahi S, Nazari H. Evaluation of the incidence and outcome of fetal hydronephrosis prenatally diagnosed by ultrasound. Acta Medica Iranica. 2005;43:336–339
  3. Morin L, Cendron M, Crombleholme TM, et al. Minimal hydronephrosis in the fetus: Clinical significance and implications for management. J Urol. 1996;155:2047–2049
  4. Feldman DM, DeCambre M, Borgida A, et al. Evaluation and follow up of fetal hydronephrosis. J Ultrasound Med. 2001;20:1065–1069
  5. Ransley PG, Risdon RA. Renal papillary morphology in infants and young children. Urol Int. 1975;3:111–113
  6. Ardissino G, Avolio L, Dacco V, et al. Long-term outcome of vesicoureteral reflux associated chronic renal failure in children (Data from the Italkid project). J Urol. 2004;172:305–310
  7. Levi S, Schaaps JP, De Havay P, et al. End-result of routine ultrasound screening for congenital anomalies: The Belgian Multicentric Study 1984-92. Ultrasound Obstet Gynecol. 1995;5:366–371
  8. Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: Introduction to the system used by the society for fetal urology. Pediatr Radiol. 1993;23:478–480
  9. Langer B. Fetal pyelectasis. Ultrasound Obstetr Gynecol. 2000;16:1–5
  10. Chitty LS, Altman DG. Charts of fetal size: Kidney and renal pelvis measurements. Prenat Diagn. 2003;23:891–897
  11. Baraibar Castello R, Porta Ribera R. Seguimiento postnatal del feto con pielectasia: un problema no resuelto. An Esp Pediatr. 2000;53:441–448
  12. Dudley JA, Haworth JM, McGraw ME, et al. Clinical relevance and implications of antenatal hydronephrosis. Arch Dis Child. 1997;76:F31–F34
  13. Ismaili K, Avni FE, Hall M. Results of systematic voiding cystourethrography in infants with antenatally diagnosed renal pelvis dilation. J Pediatr. 2002;141:21–24
  14. Moorthy I, Joshi N, Cook JV, et al. Antenatal hydronephrosis: Negative predictive value of normal postnatal ultrasound, a 5-year study. Clin Radiol. 2003;58:964–970
  15. Avni EF, Ayadi K, Rypens F, et al. Can careful ultrasound examination of the urinary tract exclude vesicoureteric reflux in the neonate?. Br J Radiol. 1997;70:977–982
  16. Ismaili K, Avni FE, Wissing KM, et al. Long-term clinical outcome of infants with mild and moderate fetal pyelectasis: Validation of neonatal ultrasound as a screening tool to detect significant nephro-uropathies. J Pediatr. 2004;144:759–765
  17. Rohrschneider WK, Haufe S, Wiesel M, et al. Functional and morphological evaluation of congenital urinary tract dilatation by using combined static-dynamic MR urography: Findings in kidneys with a single collecting system. Radiology. 2002;224:683–694
  18. Avni EF, Bali MA, Regnault M, et al. MR radiography in children. Eur J Radiol. 2002;43:154–166
  19. Kirsch AJ, McMann LP, Jones RA, et al. Magnetic resonance urography for evaluating outcomes after pediatric pyeloplasty. J Urol. 2006;176:1755–1761
  20. McMann LP, Kirsch AJ, Scherz HC, et al. Magnetic resonance urography in the evaluation of prenatally diagnosed hydronephrosis and renal dysgenesis. J Urol. 2006;176:1786–1792
  21. Kaneyama K, Yamataka A, Someya T, et al. Magnetic resonance urographic parameters for predicting the need for pyeloplasty in infants with prenatally diagnosed severe hydronephrosis. J Urol. 2006;176:1781–1785
  22. Tripp BM, Homsy YL. Neonatal hydronephrosis—the controversy and the management. Pediatr Nephrol. 1995;9:503–509
  23. Acton C, Pahuja M, Opie G, et al. A 5-year audit of 778 neonatal renal scans(Part I): Perplexing pyelectasis and suggested protocol for investigation. Australs Radiol. 2003;47:349–353
  24. Moothly I, Joshi N, Vok JV, et al. Antenatal hydronephrosis:negative predictive value of normal postnatal ultrasound, a 5-year study. Clin Radiol. 2003;58:964–970
  25. Garin EH, Campos A, Homsy Y. Primary vesicoureteral reflux; review of current concepts. Pediatr Nephrol. 1998;12:249–256
  26. Piepsz A, Blaufox MD, Gordon I, et al. Scientific Committee of Radionuclides in Nephrourology Consensus on renal cortical scintigraphy in children with urinary tract infection. Semin Nucl Med. 1999;29:160–174
  27. Rossleigh MA. The point of view of the paediatric nuclear medicine physician. In:  Prigent A,  Piepsz A editor. Functional Imaging in Nephro-Urology. London: Taylor and Francis; 2006;p. 223–232
  28. Piepsz A, Ham H. Pediatric applications of renal nuclear medicine. Semin Nucl Med. 2006;36:16–35
  29. Piepsz A, Colarinha P, Gordon I, et al. Guidelines for 99mTc-DMSA scintigraphy in children. Eur J Nucl Med. 2001;28:BP37–BP41
  30. Mandell GA, Eggli DF, Gilday DL, et al. Procedure guideline for renal cortical scintigraphy in children. Soc Nucl Med J Nucl Med. 1997;38:1644–1646
  31. Verboven M, Ham HR, Josephson S, et al. 99m Tc-DMSA uptake in obstructed kidneys (How inaccurate are the 5 hr measurements?). Nucl Med Commun. 1987;8:45–48
  32. Orsola A, Parra Roca J, Estorch Cabrera M, et al. Congenital renal abnormalities in neonates with fetal vesicoureteral reflux (Detection by 99m-technetium(m)-dimercaptosuccinic acid renal scintigraphy). An Pediatr (Barc). 2003;59:345–351
  33. Nguyen HT, Bauer SB, Peters CA, et al. 99m Technetium dimercapto-succinic acid renal scintigraphy abnormalities in infants with sterile high grade vesicoureteral reflux. J Urol. 2000;164:1674–1678
  34. Josephson S. Antenatally detected, unilateral dilatation of the renal pelvis: A critical review. 1 (Postnatal non-operative treatment 20 years on-is it safe?). Scand J Urol Nephrol. 2002;36:243–250
  35. Josephson S. Antenatally detected, unilateral dilatation of the renal pelvis:a critical review. 2 (Postnatal non-operative treatment—Long-term hazards, urgent research). Scand J Urol Nephrol. 2002;36:251–259
  36. Eskild-Jensen A, Gordon I, Piepsz A, et al. Interpretation of the renogram: problems and pitfalls in hydronephrosis in children. BJU Int. 2004;94:887–892
  37. Eskild Jensen A, Gordon I, Piepsz A, et al. Congenital unilateral hydronephrosis: A review of the impact of diuretic renography on clinical treatment. J Urol. 2005;173:147–156
  38. Kuyvenhoven JD, Ham HR, Piepsz A. The estimation of renal transit using renography—our opinion. Nucl Med Commun. 2004;25:1223–1231
  39. Frökiaer J. The nuclear medicine techniques. In:  Prigent A,  Piepsz A editor. Functional Imaging in Nephro-Urology. London: Taylor and Francis; 2006;p. 103–115
  40. Gordon I, Colarinha P, Fettich J, et al. Guidelines for standard and diuretic renography in children. Eur J Nucl Med. 2001;28:BP21–BP30
  41. Donoso G, Kuyvenhoven JD, Ham H, et al. 99mTc-MAG3 diuretic renography in children: A comparison between F0 and F+20. Nucl Med Commun. 2003;24:1189–1193
  42. Donoso G, Ham H, Tondeur M, et al. Influence of early furosemide injection on the split renal function. Nucl Med Commun. 2003;2:791–795
  43. Ozcan Z, Anderson PJ, Gordon I. Robustness of estimation of differential renal function in infants and children with unilateral prenatal diagnosis of a hydronephrotic kidney on dynamic renography: How real is the supranormal kidney?. Eur J Nucl Med Mol Imaging. 2006;33:738–744
  44. Chaiwatanarat T, Padhy AK, Bomanji JB, et al. Validation of renal output efficiency as an objective quantitative parameter in the evaluation of upper urinary tract obstruction. J Nucl Med. 1993;34:845–848
  45. Nimmon CC, Samal M, Britton KE. Elimination of the influence of total renal function on renal output efficiency and normalized residual activity. J Nucl Med. 2004;45:587–593
  46. Piepsz A, Ham H. Factors influencing the accuracy of renal output efficiency. Nucl Med Commun. 2000;21:1009–1013
  47. Piepsz A, Tondeur M, Ham H. NORA: A simple and reliable parameter for estimating renal output with or without frusemide challenge. Nucl Med Commun. 2000;21:317–323
  48. Piepsz A, Kuyvenhoven JD, Tondeur M, et al. Normalized residual activity: Usual values and robustness of the method. J Nucl Med. 2002;43:33–38
  49. Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med. 1996;37:1883–1890
  50. Piepsz A, Colarinha P, Gordon I, et al. Guidelines for glomerular filtration rate determination in children. Eur J Nucl Med. 2001;28:BP31–BP36
  51. Picciotto G, Cacace G, Cesana P, et al. Estimation of chromium-51 ethylene diamine tetra-acetic acid plasma clearance: A comparative assessment of simplified techniques. Eur J Nucl Med. 1992;19:30–35
  52. Bröchner-Mortensen J, Haahr J, Christoffersen J. A simple method for accurate assessment of the glomerular filtration rate in children. Scand J Clin Lab Invest. 1974;33:139–143
  53. Chantler C, Barratt TM. Estimation of glomerular filtration rate from plasma clearance of 51Cr-edetic acid. Arch Dis Child. 1972;47:613–617
  54. Fleming JS, Zivanovic MA, Blake GM, et al. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun. 2004;25:759–769
  55. Groth S. Calculation of Cr-51 EDTA clearance in children from the activity in one plasma sample by transformation of the bi-exponential plasma time-activity curve into a monoexponential with identical integral area below the time activity curve. Clin Physiol. 1984;4:61–74
  56. Ham HR, Piepsz A. Estimation of glomerular filtration rate in infants and in children using a single-plasma sample method. J Nucl Med. 1991;32:1294–1297
  57. Ham HR, De Sadeleer C, Hall , et al. Which single blood sample method should be used to estimate 51Cr-EDTA clearance in adolescents?. Nucl Med Commun. 2004;25:155–157
  58. Piepsz A, Tondeur M, Ham H. Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging. 2006;33:1477–1482
  59. Mandell GA, Eggli DF, Gilday DL, et al. Society of Nuclear Medicine Procedure guideline for radionuclide cystography in children. J Nucl Med. 1997;38:1650–1654
  60. Shah SM, Glassberg KI. Multicystic dysplastic kidney disease. In:  Gearhart JP,  Rink RC,  Mouriquand PDE editor. Pediatric Urology. Philadelphia: WB Saunders; 2001;p. 279–287
  61. Beck AD. The effect of intrauterine urinary obstruction upon the development of the fetal kidney. J Urol. 1971;105:784–789
  62. Hildebrandt O. Weiterer Beitrag zur patologischen Anatomie der Nierengeschwulste. Arch Clin Chir. 1894;48:343–354
  63. Al Khaldi N, Watson AR, Zuccollo J, et al. Outcome of antenatally detected cystic dysplastic kidney disease. Arch Dis Child. 1994;70:520–522
  64. Avni EF, Thoua Y, Lalmand B, et al. Multicystic dysplastic kidney in children: Natural history from in utero diagnosis and postnatal follow up. J Urol. 1987;138:1420–1424
  65. Perez LM, Naidu SI, Joseph DB. Outcome and cost analysis of operative versus nonoperative management of neonatal mutlicystic dysplastic kidneys. J Urol. 1998;160:1207–1211
  66. Mathiot A, Liard A, Eurin D, et al. Prenataly detected multicystic renal dysplasia and associated anomalies of the genito-urinary tract. J Radiol. 2002;83:731–735
  67. Heikkinen ES, Herva R, Lanning P. Multicystic disease: A clinical and histological study of 13 patients. Ann Chir Gynaecol. 1980;69:15–22
  68. Piepsz A, Prigent A, Hall M, et al. At what level of unilateral renal impairment does contralateral functional compensation occur?. Pediatr Nephrol. 2005;20:1593–1598
  69. Flack CE, Bellinger MF. The multicystic dysplastic kidney and contralateral vesicoureteral reflux: Protection of the solitary kidney. J Urol. 1993;1873–1874
  70. Ismaili K, Avni FE, Alexander M, et al. Routin voiding cystourethrography is of no value in neonates with unilateral multicystic dysplastic kidney. J Pediatr. 2005;146:759–763
  71. Wacksman J, Phipps L. Report of the multicystic kidney registry:preliminary findings. J Urol. 1993;150:1870–1872
  72. Dinneen MD, Duffy PG. Posterior urethral valves. Br J Urol. 1996;78:275–281
  73. Godley MJ. Vesicoureteral reflux: Pathophysiology and experimental studies. In:  Gearhart JP,  Rink RC,  Mouriquand PDE editor. Pediatric Urology. Philadelphia: WB Saunders; 2001;p. 359–381
  74. Avni EF, Schulman CC. The origin of vesicoureteric reflux in male newborn: Further evidence in favor of a transient fetal urethral obstruction. Br J Urol. 1996;78:454–459
  75. Jodal U. The natural history of bacteriuria in childhood. Infect Dis Clin North Am. 1987;1:713–729(review)
  76. Hansson S, Dhamey M, Sigstrom O, et al. Dimercapto-succinic acid scintigraphy instead of voiding cystourethrography for infants with urinary tract infection. J Urol. 2004;172:1071–1073
  77. Hansson S. The point of view of the paediatric nephrologist. In:  Prigent A,  Piepsz A,  Mouriquand PDE editor. Functional Imaging in Nephro-Urology. London, UK: Taylor and Francis; 2006;p. 232–239
  78. Edwards D, Normand IC, Prescod N, et al. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. BMJ. 1977;2:285–288
  79. Tsai JF, Wang FY, Tsay TC. Asymptomatic vesicoureteral reflux detected by neonatal ultrasonographic screening. Pediatr Nephrol. 1998;12:206–209
  80. Marra G, Barbieri G, Moioli C, et al. Mild fetal hydronephrosis indicating vesico-ureteral reflux. Arch Dis Child. 1994;70:F147–F150
  81. Stocks A, Richards D, Frentzen B, et al. Correlation of prenatal renal pelvic anteroposterior diameter with outcome in infancy. J Urol. 1996;155:1050–1052
  82. Jaswon MS, Dibble L, Puri S, et al. Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child. 1999;80:F135–F138
  83. Ismaili K, Hall M, Piepsz A, et al. Primary vesico-ureteral reflux detected among neonates with a history of fetal renal pelvis dilatation: A prospective clinical and imaging study. J Pediatr. 2006;148:222–227
  84. Acton C, Pahuja M, Opie G, et al. A 5-year audit of 778 neonatal renal scans (Part I): Perplexing pyelectasis and suggested protocol for investigation. Austr Radiol. 2003;47:349–353
  85. Moorthy I, Joshi N, Cook JV, et al. Antenatal hydronephrosis: Negative predictive value of normal postnatal ultrasound, a 5-year study. Clin Radiol. 2003;58:964–970
  86. Yeung CK, Godley ML, Dhillon HK, et al. The characteristics of primary vesico-ureteric reflux in male and female infants with prenatal hydronephrosis. Br J Urol. 1997;80:319–327
  87. Mouriquand P, Whitten M, Pracros JP. Pathophysiology, diagnosis and management of prenatal upper tract dilatation. Prenat Diagn. 2001;21:942–951
  88. Ismaili K, Hall M, Piepsz A, et al. Insights into the pathogenesis and natural history of fetuses with renal pelvis dilatation. Eur Urol. 2005;48:207–214
  89. Ismaili K, Avni FE, Wissing KM, et al. Current management of infants with fetal renal pelvis dilatation: a survey by French-speaking pediatric nephrologists and urologists. Pediatr Nephrol. 2004;19:966–971
  90. Ulman I, Jayanthi VR, Koff SA. The long-term follow-up of newborns with severe unilateral hydronephrosis initially treated nonoperatively. J Urol. 2000;164:1101–1105
  91. Subramanian R, Kouriefs C, Dickson AP. Antenatally detected pelvi-ureteric junction obstruction: Concerns about conservative treatment. BJU Int. 1999;84:33533
  92. Feldman DM, DeCambre M, Kong E, et al. Evaluation and follow up of fetal hydronephrosis. J Ultrasound Med. 2001;20:1065–1069
  93. Ransley PG, Dhillon HK, Gordon I, et al. The postnatal management of hydronephrosis diagnosed by prenatal ultrasound. J Urol. 1990;194:584–587
  94. Koff SA. The beneficial and protective effects of hydronephrosis. APMIS Suppl. 2003;109:7–12
  95. Chevalier RL, Chung KH, Smith CD, et al. Renal apoptosis and clustering following ureteral obstruction: The role of maturation. J Urol. 1996;156:1474–1479
  96. Chevalier RL, Gomez RA, Jones EE. Development determinants of recovery after relief of partial ureteral obstruction. Kidney Int. 1988;33:775–779
  97. Josephson S. Experimental obstructive hydronephrosis in newborn rats (III Long term effects on renal function). J Urol. 1983;129:396–400
  98. Chevalier RL. Biomarkers of congenital obstructive nephropathy: Past, present and future. J Urol. 2004;172:852–857
  99. Murer L, Benetti E, Centi S, et al. Clinical and molecular markers of chronic interstitial nephropathy in congenital unilateral ureteropelvic junction in obstruction. J Urol. 2006;176:2668–2673
  100. Piepsz A, Hall M, Ham HR, et al. Radioisotopic evaluation of the renal parenchymal function in children with ureteropelvic junction obstruction (A retrospective study). Eur J Pediatr. 1986;145:207–210
  101. Whitten SM, Wilcox DT. Duplex systems. Prenat Diagn. 2001;21:952–957
  102. Ismaili K, Hall M, Ham H, et al. Evolution of individual renal function in children with unilateral complex renal duplication. J Pediatr. 2005;147:208–212
  103. Peppas DS, Skoog SJ, Canning DA, et al. Nonsurgical management of primary vesicoureteric reflux in complete ureteral duplication (Is it justified?). J Urol. 1991;146:1594–1595
  104. Ossandon F, Androulakakis P, Ransley PG. Surgical problems in pelviureteral junction obstruction of the lower moiety in incomplete duplex systems. J Urol. 1981;125:871–872
  105. Avni FE, Dacher JN, Stallenberg B, et al. Renal duplications: the impact of perinatal US on diagnosis and management. Eur Urol. 1991;20:43–48
  106. Decter RM. Renal duplication and fusion anomalies. Pediatr Clin North Am. 1997;44:1323–1341

PII: S0001-2998(07)00029-3

doi: 10.1053/j.semnuclmed.2007.02.008

Seminars in Nuclear Medicine
Volume 37, Issue 4 , Pages 249-260 , July 2007

Article Tools

* Image Usage & Resolution